The study was conducted in the Department of Ophthalmology at the University of Illinois at Chicago. Fifty-two patients with RP (n = 42) or Usher syndrome type II (n = 10) were included, and informed consent was obtained. The diagnosis of RP was based on the history of night blindness, impairment in peripheral visual fields, reduction in electroretinogram rod and cone amplitudes, and presence of characteristic fundus pigmentary changes. Usher II patients had the same clinical features as RP, additional moderate congenital sensorineural hearing loss, and absence of vestibular dysfunction. This study followed the tenets of Declaration of Helsinki and was approved by an institutional review board at the University of Illinois.
All patients with a diagnosis of RP or Usher syndrome type II, who were seen by the authors during clinical examination or who returned to participate in a project relating to cystoid macular edema (CME) in RP patients, were included in the present study if they were willing to undergo OCT testing. Exclusion criteria included inability to hold steady fixation, previous history of glaucoma or raised intraocular pressure of more than 21 mm Hg., uveitis, diabetic retinopathy, optic nerve head drusen, refractive error of more than ±6 D sphere or ±2 D cylinder, dense media opacity sufficient to hinder OCT examination, and sector RP.
All patients underwent complete eye examination, including best-corrected visual acuity using an early treatment of diabetic retinopathy chart (The Lighthouse, Long Island City, NY), slit lamp examination, and intraocular pressure measurement with Goldmann applanation tonometry. Both eyes were dilated with 2.5% phenylephrine and 1% tropicamide. Fundus examination was performed using stereobiomicroscopy, and optic disc pallor was graded as normal-mild, mild-moderate, or moderate-severe. Ultrasonic axial length and pachymetry measurements were then made (Nidek Inc., Fremont, CA).
OCT was performed using Optovue technology (RTvue versions 1.2.6, 2.0.3.2, and 3.0; Optovue Inc., Fremont, CA). Although the scans were obtained using the 3 software versions, the final analysis of the RNFL thickness selectively used version 3.0. The NMH
4 protocol was used for scan acquisition. Internal fixation was used for all patients. The total time for a single scan acquisition was 0.37 seconds. Scans were accepted only if they had a signal strength index greater than 35 and were free of artifacts. RNFL thickness was measured in each eye 3 times, and data were used only if they were reproducible, within normal or abnormal range, in 2 or more acquisitions. The contour of the optic nerve head was manually traced using the fundus picture generated by the OCT
(Fig. 1C) .
RNFL thickness was measured automatically by the existing software at a diameter of 3.45 mm around the center of the optic disc. The total number of A-scans at that circumference was 2225. RNFL thickness was measured in the temporal (316°-45°), superior (46°-135°), nasal (136°-225°), and inferior (226°-315°) quadrants. OCT software automatically measured 4 smaller segments within each quadrant. Data thus obtained were compared with the normative database provided with the software, taking the patient age and size of the optic disc into account. The RNFL was considered abnormally thin if its value was less than the 5th percentile of the age- and optic disc size-adjusted normal value and thick if it was more than the 95th percentile. Abnormal thinning or thickness in 2 of these smaller sectors within a quadrant, if reproducible, was considered significant. Data from both the eyes were averaged and used for the final analysis.
For detecting macular edema, the radial slicer protocol was used. It consisted of twelve 6-mm radial scans at 15° intervals passing through the center of the fovea. All 12 scans were acquired simultaneously, and the total time taken for their acquisition was 0.27 seconds. Each radial line consisted of 1024 A-scans.